SCHEMBL19863074

SCHEMBL19863074

c1ccc(-c2cc(-c3ccccc3)nc(-n3c4ccccc4c4c(-c5ccc6oc7ccccc7c6c5)cc5c6ccccc6oc5c43)c2)cc1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 2/20 0.34
KMT2A Q03164 1/20 0.34
PLA2G2A P14555 1/20 0.31
PLA2G4A P47712 1/20 0.31
ALOX5 P09917 1/20 0.31
PIM1 P11309 1/20 0.31
CSNK2A2 P19784 1/20 0.31
CSNK2B P67870 1/20 0.31
PIM3 Q86V86 1/20 0.31
PIM2 Q9P1W9 1/20 0.31
CHEK2 O96017 1/20 0.31
KDM4E B2RXH2 2/20 0.30
ALDH1A1 P00352 2/20 0.30
MAPT P10636 2/20 0.30
HPGD P15428 2/20 0.30
PTPRF P10586 1/20 0.30
PTPN2 P17706 1/20 0.30
PTPN1 P18031 1/20 0.30
ALOX15 P16050 1/20 0.30
TSHR P16473 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19863075 0.94 KDM4E (0.34) MAPK1KMT2AALOX5KDM4EALDH1A1
SCHEMBL18594201 0.93 MAPK1 (0.35) MAPK1KMT2APLA2G2APLA2G4AALOX5
SCHEMBL19862897 0.91 KDM4E (0.32) MAPK1KMT2AKDM4EALDH1A1MAPT
SCHEMBL19863068 0.91 MAPT (0.37) MAPK1KMT2AALOX5CHEK2KDM4E
SCHEMBL19862901 0.90 KDM4E (0.35) MAPK1KMT2AKDM4EALDH1A1MAPT
SCHEMBL19863055 0.89
SCHEMBL19862898 0.89 KDM4E (0.32) MAPK1KMT2AKDM4EALDH1A1MAPT
SCHEMBL18594179 0.87 KMT2A (0.34) MAPK1KMT2APLA2G2APLA2G4AALOX5
SCHEMBL19863072 0.87 MAPT (0.34) MAPK1KMT2AALOX5KDM4EALDH1A1
SCHEMBL18594202 0.86

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10230056-B2 Heterocyclic compound and organic light emitting element comprising same LG CHEM, LTD. (KR) 2019-03-12 US disclosed
US-20180047914-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2018-02-15 US disclosed
US-20180047914-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2018-02-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10230056-B2 Heterocyclic compound and organic light emitting element comprising same CRY1, CRY2, NR2E3 MAPK1 3622/4885KMT2A 177/4885PLA2G2A 4191/4885
US-20180047914-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME CRY1, CRY2, NR2E3 MAPK1 3622/4885KMT2A 177/4885PLA2G2A 4191/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.